Fundamental Valuation Report Clearwater Paper(CLW:NYS) Basic Materials:Paper & Paper Products This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$34.98 (USD) 04/21/2021 Weighted Valuation$40.04 (USD) Overall RatingUndervalued by 14.5% Valuation Models …
Clearwater Paper (CLW:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Chimerix(CMRX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$8.25 (USD) 04/21/2021 Weighted Valuation$6.79 (USD) Overall RatingOvervalued by 17.8% Valuation Models Comparables: $6.79 (USD) Valuation Methods This …
Chimerix (CMRX:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report CenterPoint Energy(CNP:NYS) Utilities:Utilities – Regulated Electric This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$24.29 (USD) 04/21/2021 Weighted Valuation$24.20 (USD) Overall RatingFairly valued to slightly Overvalued by 0.4% …
CenterPoint Energy (CNP:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report CCL Industries(CCL.B:TSE) Consumer Cyclical:Packaging & Containers This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$69.10 (CAD) 04/20/2021 Weighted Valuation$71.25 (CAD) Overall RatingFairly valued to slightly Undervalued by 3.1% …
CCL Industries (CCL.B:TSE) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Cross Country Healthcare(CCRN:NAS) Industrials:Staffing & Employment Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$12.67 (USD) 04/20/2021 Weighted Valuation$11.51 (USD) Overall RatingOvervalued by 9.1% Valuation Models …
Cross Country Healthcare (CCRN:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Cidara Therapeutics(CDTX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$2.03 (USD) 04/20/2021 Weighted Valuation$1.92 (USD) Overall RatingOvervalued by 5.4% Valuation Models Comparables: $1.67 (USD) (in order …
Cidara Therapeutics (CDTX:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Cerus(CERS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$5.84 (USD) 04/20/2021 Weighted Valuation$5.90 (USD) Overall RatingFairly valued to slightly Undervalued by 1.0% Valuation Models Adjusted Book …
Cerus (CERS:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Compugen(CGEN:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$8.25 (USD) 04/20/2021 Weighted Valuation$8.22 (USD) Overall RatingFairly valued to slightly Overvalued by 0.4% Valuation Models Comparables: $8.62 (USD) …
Compugen (CGEN:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Coherus BioSciences(CHRS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.27 (USD) 04/20/2021 Weighted Valuation$27.53 (USD) Overall RatingUndervalued by 93.0% Valuation Models Discounted Cash Flow: $27.53 (USD) …
Coherus BioSciences (CHRS:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Cigna(CI:NYS) Healthcare:Healthcare Plans This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$253.37 (USD) 04/20/2021 Weighted Valuation$260.40 (USD) Overall RatingFairly valued to slightly Undervalued by 2.8% Valuation Models Comparables: $278.15 …
Cigna (CI:NYS) Fundamental Valuation Report Read more »
Read More